THE LABORATORY REPORT Fall 2014 Page 8 SPOTLIGHT ON FORMER TRAINEES: Where Are They Now? Dr. Jian Chen completed his residency in clinical pathology and fellowship in transfusion medicine and blood banking at the Department of Pathology and Genomic Medicine at Houston Methodist Hospital in 2013. He is currently Assistant Professor of Clinical Transfusion Medicine and Associate Director of the Coagulation Laboratory at the Ohio State University College of Medicine. Dr. Chen received his M.D. from Shandong Medical University in China in 1993 and then joined the Institute of Space Medicine and Engineering, also in China, as a postgraduate research associate. In 2001, he was accepted into the Department of Pathology at the University of Alabama at Birmingham (UAB), where he received his Ph.D. in 2005. He then elected to continue his research training as a postdoctoral fellow at the UAB School of Medicine. He is board certified in clinical pathology and transfusion medicine. After completion of his residency and fellowship training, Dr. Chen was recruited to Ohio State University (OSU) in 2013. His clinical duties include apheresis and blood banking, management of the coagulation laboratory, cytogenetics, and chemistry signout. When asked about his new position, Dr. Chen stated, “I am enjoying my first year as an attending physician. The OSU transfusion medicine service is similar to that at Houston Methodist, so I had no difficulty adjusting.” In addition to his clinical duties, Dr. Chen is an accomplished research scientist. While at UAB, his research focused on immunology and was extended to hematopoiesis as he worked with Drs. Leveque and Chandler at Houston Methodist Hospital. Dr. Chen has co-authored 19 peer-reviewed articles, one book chapter, and presented his research at numerous national and international scientific meetings. As a new faculty at OSU, Dr. Chen is currently in the process of identifying a mentor who will assist him on his path to becoming an independent physician scientist. “I know that I received superior training at Houston Methodist that prepared me for my current position. I am honored to be a member of the Methodist family.” - Dr. Jian Chen Upcoming Department of Pathology and Genomic Medicine Grand Rounds On November 4, 2014, Dr. Maryalice Stetler-Stevenson will present her talk titled “Flow cytometric biomarkers for diagnosis and prognosis in plasma cell dyscrasia.” Dr. Stetler-Stevenson is a staff clinician and Chief of the Flow Cytometry Unit in the Laboratory of Pathology at the Center for Cancer Research at the National Cancer Institute. Dr. Stetler-Stevenson’s research focuses on diagnostic clinical flow cytometry and immunophenotyping of hematolymphoid malignancies. On December 2, 2014, Dr. Chen Liu will present his work on “Alteration of genome-wide epigenomic regulation in liver carcinogenesis.” Dr. Liu is the Associate Chair of the Department of Pathology and Director of Gastrointestinal and Liver Pathology Division at the University of Florida. His research interests encompass pathogenesis of liver and pancreatic cancers, as well as the mechanisms associated with Graft-Versus-Host Disease. His recent work defines epigenetic changes associated with alcohol abuse and hepatitis that promote liver carcinogenesis, as well as provides experimental evidence for metabolism-induced regulation of liver cancer epigenetics.
To see the actual publication please follow the link above